Rabbit Recombinant Monoclonal MARK4 phospho T214 + MARK2 phospho T208 + MARK3 phospho T234 + MARK1 phospho T215 antibody. Suitable for Dot, WB, I-ELISA and reacts with Human amd Synthetic peptide samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
IP | IHC-P | Flow Cyt | ICC/IF | Dot | WB | I-ELISA | |
---|---|---|---|---|---|---|---|
Human | Not recommended | Not recommended | Not recommended | Not recommended | Expected | Tested | Expected |
Mouse | Not recommended | Not recommended | Not recommended | Not recommended | Predicted | Predicted | Predicted |
Rat | Not recommended | Not recommended | Not recommended | Not recommended | Predicted | Predicted | Predicted |
Synthetic peptide | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended | Tested |
Synthetic peptide - Human | Not recommended | Not recommended | Not recommended | Not recommended | Tested | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide - Human, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide - Human, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide - Human, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide - Human, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/10000 - 1/50000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info 1000 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human | Dilution info - | Notes - |
Select an associated product type
Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells.
MARK3 phospho T234, MARK4 phospho T214, MARK1 phospho T215
EMK1, MARK2, Serine/threonine-protein kinase MARK2, ELKL motif kinase 1, MAP/microtubule affinity-regulating kinase 2, PAR1 homolog, PAR1 homolog b, EMK-1, Par-1b, Par1b
Rabbit Recombinant Monoclonal MARK4 phospho T214 + MARK2 phospho T208 + MARK3 phospho T234 + MARK1 phospho T215 antibody. Suitable for Dot, WB, I-ELISA and reacts with Human amd Synthetic peptide samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
This antibody detects MARK4 phosphorylated at Threonine 214, MARK2 phosphorylated at Threonine 208, MARK3 phosphorylated at Threonine 234 and MARK1 phosphorylated at Threonine 215.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Westernblot analysis of ab126731 at a 1/20 dilution. Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) was used as a scondary antibody at 1/20000 dilution.
Lane 1: HEK-293 (Human embryonic kidney epithelial cell) transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate 15μg
Lane 2: HEK-293 transfected with MARK1 expression vector containing a myc-His-tag®, whole cell lysate 15μg
Lane 3: HEK-293 transfected with MARK1 expression vector containing a myc-His-tag®, whole cell lysate 15μg, then the membrane treated with Alkaline Phosphatase for 1 hour
Lane 4: HEK-293 transfected with MARK2 expression vector containing a myc-His-tag®, whole cell lysate 15μg
Lane 5: HEK-293 transfected with MARK2 expression vector containing a myc-His-tag®, whole cell lysate 15μg, then the membrane treated with Alkaline Phosphatase for 1 hour
Lane 6: HEK-293 transfected with MARK3 expression vector containing a myc-His-tag®, whole cell lysate 15μg
Lane 7: HEK-293 transfected with MARK3 expression vector containing a myc-His-tag®, whole cell lysate 15μg, then the membrane treated with Alkaline Phosphatase for 1 hour
Lane 8: HEK-293 transfected with MARK4 expression vector containing a myc-His-tag®, whole cell lysate 15μg
Lane 9: HEK-293 transfected with MARK4 expression vector containing a myc-His-tag®, whole cell lysate 15μg, then the membrane treated with Alkaline Phosphatase for 1 hour
Exposure time:
Lane 1 – 3, 6 - 9: 180 seconds
Lane 4 - 5: 7 seconds
Endogenous MARK proteins are observed at ~110 kDa reported by PMID: 9108484 and 16238695
All lanes: Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731)
Indirect ELISA antibody dose-response curve using ab126731 between 0-10000 ng/ml. Antigen concentration of 500 ng/mL. An alkaline phosphatase-conjugated goat anti-rabbit IgG (H+L) (1/2500) was used as the secondary antibody.
Dot Blot using ab126731 at a 1/1000 dilution and Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at a 1/100000 dilution
Lane 1: Human MARK1 (T215) phospho peptide
Lane 2: Human MARK1 non-phospho peptide
Lane 3: Human MARK2 (T208) phospho peptide
Lane 4: Human MARK2 non-phospho peptide
Lane 5: Human MARK3 (T234) phospho peptide
Lane 6: Human MARK3 non-phospho peptide
Lane 7: Human MARK4 (T214) phospho peptide
Lane 8: Human MARK4 non-phospho peptide
All lanes: Western blot - Anti-MARK4 (phospho T214) + MARK2 (phospho T208) + MARK3 (phospho T234) + MARK1 (phospho T215) antibody [EPR5463] (ab126731) at 1/10000 dilution
Lane 1: SH-SY5Y cell lysate, untreated at 10 µg
Lane 2: SH-SY5Y cell lysate, treated with Okadaic acid and Calyculin A at 10 µg
All lanes: HRP labelled goat anti-rabbit at 1/2000 dilution
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody.
Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com